Efficacy of Tirzepatide in People with Young-Onset T2D in the SURPASS Program In this medfyle Tirzepatide improves HbA1c, weight, and cardiometabolic markers in both young-onset and later-onset type 2 diabetes
Still, there are limitations: higher dropout rates due to adverse effects in the semaglutide group, possible unblinding due to gastrointestinal side effects and weight loss, and the cerebrospinal fluid (CSF) sub-study was much smaller than the main trial. What are the real-world implications
Avoid high-dose fiber supplements in the first 23 weeks, as they can worsen bloating when combined with slower transit times
For general guidance only, your provider tailors nutrition advice to your needs
15 mg/semana es la dosis mxima aprobada y estudiada en ensayos pivotales
The team behind this new analysis aimed to evaluate how much the CMS decision could impact healthcare costs in the years ahead, exploring data from the National Health and Nutrition Examination Survey